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Introduction
Although uncommon, splenic artery aneurysms account 
for approximately 60% of  all visceral artery aneurysms and 
are the third most common intraabdominal aneurysm 
ranking only behind aneurysms of  the aorta and iliac arter-
ies [1,2]. Most splenic artery aneurysms are asymptomatic 
when diagnosed. Treatment of  splenic artery aneurysms is 
based on size. Aneurysms less than 2 cm are associated with 
a less than 2% risk of  rupture and are therefore generally 
followed [1,2]. Aneurysms larger than 2 cm are repaired, 
usually by elective surgery. We present a case in which per-
cutaneous thrombin injection was used for treatment of  a 
splenic artery aneurysm.
Case Report
A 53-year old nulliparous female originally presented to 
our institution for work-up of  her noncardiac chest pain. 
An upper endoscopy, esophageal motility study, and chest 
computed tomography (CT) were then ordered in an at-
tempt to find a causative factor for the patient’s pain. Chest 
CT demonstrated a 2.7x2.0 cm saccular aneurysm from 
the middle third of  the splenic artery (Figure 1) and was 
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Figure 1. Enhanced CT, in both the axial (A) and coronal 
oblique (B) planes, demonstrates a saccular aneurysm (A) 
from the middle third of the splenic artery (arrow).
A
B
otherwise negative. All other exams were negative. 
Vascular surgery was than consulted and recommended 
repair of  the aneurysm. After consultation with interven-
tional radiology, the patient was given the option of  elective 
surgery or percutaneous treatment. Transarterial emboliza-
tion was not considered an option because of  the location 
of  the aneurysm and the tortuosity of  the splenic artery. 
The patient chose to under go percutaneous treatment of  
the aneurysm with sonographically guided thrombin injec-
tion.
The patient was admitted to our institution the day of  
her procedure and was later taken to the ultrasound labora-
tory. Following informed consent, the aneurysm was local-
ized with ultrasound. Intravenous (IV) conscious sedation 
and local anesthetic were utilized.
Using a transhepatic approach and direct ultrasound 
visualization (Figure 2), the aneurysm was then accessed 
with a 20-gauge needle (Figure 3). 
A total of  1500 units of  thrombin diluted in 1.5 cc’s of  
saline was injected into the aneurysm causing its complete 
thrombosis. The splenic artery remained patent during the 
procedure, and the patient remained asymptomatic. 
Follow-up ultrasound examination 2 and 24 hours after 
the procedure (Figure 4) demonstrated complete thrombo-
sis of  the aneurysm with patent splenic artery and a normal 
appearing spleen. Follow-up CT examination 3 months 
following the procedure showed that the aneurysm had 
recanalized but was not changed in size. Patient underwent 
laparoscopic repair of  the aneurysm 3 weeks later without 
complication.
Discussion
Splenic artery aneurysm is an uncommon entity. The 
etiology and pathophysiology is not completely understood. 
Portal hypertension, pancreatitis, and multiple pregnancies 
are the most commonly mentioned predisposing factors. 
Most splenic artery aneurysms are asymptomatic when 
diagnosed and the natural history of  splenic artery aneu-
rysms has not been well studied. It has been reported that 
rupture in aneurysms less than 2-2.5 cm is rare occurring in 
less than 2% of  cases [1,2]. Splenic artery aneurysm rup-
ture, however, has an overall mortality rate of  10-25% and 
therefore elective treatment of  the aneurysm is recom-
mended in lesions exceeding 2 cm [1,2].
The two primary methods of  treatment for splenic artery 
aneurysms are surgical repair and transcatheter emboliza-
tion. Surgical repair with splenic preservation has been 
generally performed on lesions in the proximal to middle 
third of  the splenic artery. Aneurysms in the distal third are 
most often treated with resection and splenectomy.
Transcatheter embolization with coil and/or covered 
stent placement has a success rate of  approximately 85% 
and appears to have a lower overall rate of  serious compli-
cations when compared with surgery [1, 3].  However, be-
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Figure 2. Ultrasound image with color Doppler 
demonstrates turbulent flow within the splenic artery 
aneurysm (arrows) before thrombin injection.
Figure 3. Ultrasound image immediately following thrombin 
injection demonstrates needle (arrow) within the aneurysm, 
showing that blood flow has ceased.
Figure 4. Ultrasound image with color Doppler 24 hours 
after thrombin injection shows that the aneurysm (between 
the cursors) still lacks blood flow.
cause of  vessel size and tortuosity, not all aneurysms are 
accessible via the transarterial route.  Transcatheter emobo-
lization is also not without significant risks including recur-
rence and distal embolic phenomena [4].  Careful patient 
selection should be made as transarterial embolization of  
distal splenic artery aneurysms have a higher reported inci-
dence of  complication [4].  We describe the use of  percu-
taneous thrombin injection for treatment of  a splenic artery 
aneurysm.
In 1986 Cope and Zeit first reported the use of  percuta-
neous thrombin injection for the treatment of  aneurysms 
[5]. Surgery remained the preferred method of  treatment 
for aneurysms and pseudoaneurysms until 1997 when per-
cutaneous thrombin injection for treatment of  femoral ar-
tery pseudoaneurysms was first reported in the Journal of  
Vascular Surgery [6,7]. Since that time percutaneous 
thrombin injection has been proven to be a quick, safe and 
reliable method for treatment of  femoral artery pseudoan-
eurysms and has become the method of  choice in their 
treatment [8-10]. There have been reports of  the successful 
use of  percutaneous thrombin in the treatment of  
splanchnic artery aneurysms as well as pseudoaneurysms in 
the pancreatic head, superficial temporal artery, vein graft 
anastomosis, and within the renal parenchyma [11-15].  
Percutaneous treatment of  both aneurysms and pseudo-
aneurysms is not without potential complications. Throm-
bosis of  native vessels and the propagation of  distal emboli 
have been reported in both the femoral artery and the bra-
chial artery [16,17]. Thrombosis of  the native vessels may 
be related to the size of  the native vessel, the size of  the 
aneurysm neck, and possibly the amount of  thrombin in-
jected [11]. Recanalization of  pseudoaneurysms has also 
occurred, but has usually been treated with success by re-
peat percutaneous thrombin injection [9].
In our case, permanent thrombosis of  the aneurysm 
failed. This may be because the clot in the aneurysm was 
continually exposed to high blood flow within the splenic 
artery. This differs from pseudoaneurysms where the native 
artery repairs and prevents flow back into the pseudoaneu-
rysm.  
In the more recent literature, cyanoacrylate glue has 
been used in the successful transarterial treatment of  
splenic artery aneurysms [18,19].  Moreover, cyanoacylate 
glue is now used in the percutaneous translumbar treat-
ment of  type II stent-graft endoleaks.  Future investigation 
needs to be performed to see if  percutaneous treatment 
with thrombin or cyanoacylate glue will become a viable 
option for treatment of  splenic artery aneurysms.    
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